Market Cap 4.31B
Revenue (ttm) 1.39B
Net Income (ttm) -242.47M
EPS (ttm) N/A
PE Ratio 22.71
Forward PE 21.32
Profit Margin -17.47%
Debt to Equity Ratio 0.24
Volume 1,427,400
Avg Vol 801,612
Day's Range N/A - N/A
Shares Out 54.93M
Stochastic %K 72%
Beta 0.88
Analysts Strong Sell
Price Target $81.50

Company Profile

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygena...

Industry: Medical Devices
Sector: Healthcare
Phone: 44 20 3325 0660
Address:
20 Eastbourne Terrace, London, United Kingdom
SuperGreenToday
SuperGreenToday Jun. 3 at 4:14 AM
$LIVN Share Price: $73.35 Contract Selected: Dec 18, 2026 $70 Calls Buy Zone: $9.35 – $11.55 Target Zone: $17.22 – $21.04 Potential Upside: 74% ROI Time to Expiration: 198 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PrimeZoneNews
PrimeZoneNews May. 27 at 3:34 PM
$VVOS $LIVN As you can see under the section "Other Players": These are the only companies listed on Nasdaq. LIVN has a market cap of $4B, and VVOS has a market cap of $10M. https://www.marketsandmarkets.com/Market-Reports/united-states-sleep-apnea-devices-market-220821026.html
1 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 4:54 PM
$LIVN Current Stock Price: $70.43 Contracts to trade: $70.0 LIVN May 15 2026 Call Entry: $1.25 Exit: $1.79 ROI: 43% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SmartMoneyTradez
SmartMoneyTradez May. 7 at 7:33 PM
0 · Reply
Mogeyman
Mogeyman May. 7 at 6:30 PM
0 · Reply
The_Gambl3r
The_Gambl3r May. 7 at 3:09 AM
$LIVN $MDT $FMS $BAX $NUWE ** 👀👀
1 · Reply
Estimize
Estimize May. 6 at 10:06 PM
$LIVN reported 0.98 EPS and 263.30 revenue for Q1. http://www.estimize.com/intro/livn?chart=historical&metric_name=eps&utm_content=LIVN&utm
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 10:17 AM
$LIVN Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.41 up 106.82% YoY • Reported revenue of $362.3M up 14.34% YoY • LivaNova raised its full-year 2026 constant-currency revenue growth guidance to 7.0% to 8.0% and adjusted diluted EPS to $4.20 to $4.30, while maintaining adjusted free cash flow guidance at $160M to $180M.
0 · Reply
Estimize
Estimize May. 4 at 10:03 AM
Wall St is expecting 0.90 EPS for $LIVN Q1 [Reporting 05/06 BMO] http://www.estimize.com/intro/livn?chart=historical&metric_name=eps&utm_co
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 3 at 2:37 AM
$LIVN Current Stock Price: $70.26 Contracts to trade: $70.0 LIVN Mar 20 2026 Call Entry: $0.95 Exit: $1.53 ROI: 61% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on LIVN
Jette Nygaard-Andersen Joins LivaNova Board as a New Director

Jun 11, 2026, 1:44 PM EDT - 8 days ago

Jette Nygaard-Andersen Joins LivaNova Board as a New Director


LivaNova Transcript: AGM 2026

Jun 10, 2026, 10:00 AM EDT - 9 days ago

LivaNova Transcript: AGM 2026


LivaNova appoints Liddy as Chief Legal Officer

2026-06-05T13:05:33.000Z - 14 days ago

LivaNova appoints Liddy as Chief Legal Officer


LivaNova Appoints Anne Liddy as Chief Legal Officer

Jun 5, 2026, 9:00 AM EDT - 14 days ago

LivaNova Appoints Anne Liddy as Chief Legal Officer


LivaNova appoints Stefano Folli as President, Cardiopulmonary

2026-05-21T13:39:56.000Z - 4 weeks ago

LivaNova appoints Stefano Folli as President, Cardiopulmonary


LivaNova price target lowered to $76 from $78 at Baird

2026-05-07T15:51:44.000Z - 6 weeks ago

LivaNova price target lowered to $76 from $78 at Baird


LivaNova price target raised to $90 from $85 at Mizuho

2026-05-07T15:50:20.000Z - 6 weeks ago

LivaNova price target raised to $90 from $85 at Mizuho


LivaNova price target raised to $76 from $73 at Barclays

2026-05-07T11:56:34.000Z - 6 weeks ago

LivaNova price target raised to $76 from $73 at Barclays


LivaNova reports Q1 adjusted EPS 98c, consensus 90c

2026-05-07T09:56:32.000Z - 6 weeks ago

LivaNova reports Q1 adjusted EPS 98c, consensus 90c


LivaNova Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 6 weeks ago

LivaNova Earnings Call Transcript: Q1 2026


LivaNova Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 6 weeks ago

LivaNova Earnings release: Q1 2026


LivaNova Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 6 weeks ago

LivaNova Slides: Q1 2026


LivaNova Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 6 weeks ago

LivaNova Quarterly report: Q1 2026


LivaNova Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 7 weeks ago

LivaNova Proxy statement: Proxy filing


LivaNova Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 7 weeks ago

LivaNova Proxy statement: Proxy filing


LivaNova to Announce First-Quarter 2026 Results

Mar 25, 2026, 9:00 AM EDT - 3 months ago

LivaNova to Announce First-Quarter 2026 Results


LivaNova granted premarket approval for aura6000 System by FDA

2026-03-19T12:42:05.000Z - 3 months ago

LivaNova granted premarket approval for aura6000 System by FDA


LivaNova price target raised to $73 from $67 at Barclays

2026-02-27T10:40:15.000Z - 4 months ago

LivaNova price target raised to $73 from $67 at Barclays


LivaNova price target raised to $83 from $75 at Baird

2026-02-26T15:21:58.000Z - 4 months ago

LivaNova price target raised to $83 from $75 at Baird


LivaNova price target raised to $85 from $72 at Mizuho

2026-02-26T14:36:44.000Z - 4 months ago

LivaNova price target raised to $85 from $72 at Mizuho


LivaNova price target raised to $73 from $66 at Goldman Sachs

2026-02-26T11:55:03.000Z - 4 months ago

LivaNova price target raised to $73 from $66 at Goldman Sachs


LivaNova price target raised to $80 from $70 at Stifel

2026-02-25T20:55:33.000Z - 4 months ago

LivaNova price target raised to $80 from $70 at Stifel


LivaNova Earnings Call Transcript: Q4 2025

Feb 25, 2026, 8:00 AM EST - 4 months ago

LivaNova Earnings Call Transcript: Q4 2025


LivaNova Annual report: Q4 2025

Feb 25, 2026, 8:00 AM EST - 4 months ago

LivaNova Annual report: Q4 2025


LivaNova Earnings release: Q4 2025

Feb 25, 2026, 8:00 AM EST - 4 months ago

LivaNova Earnings release: Q4 2025


LivaNova Slides: Q4 2025

Feb 25, 2026, 8:00 AM EST - 4 months ago

LivaNova Slides: Q4 2025


LivaNova Annual report: Q4 2025

Feb 25, 2026, 8:00 AM EST - 4 months ago

LivaNova Annual report: Q4 2025


LivaNova sees FY26 adjusted EPS $4.15-$4.25, consensus $4.13

2026-02-25T11:12:16.000Z - 4 months ago

LivaNova sees FY26 adjusted EPS $4.15-$4.25, consensus $4.13


LivaNova reports Q4 djusted EPS 86c, consensus 81c

2026-02-25T11:05:32.000Z - 4 months ago

LivaNova reports Q4 djusted EPS 86c, consensus 81c


LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results

Jan 20, 2026, 9:00 AM EST - 5 months ago

LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results


LivaNova price target raised to $67 from $58 at Barclays

2026-01-09T12:25:56.000Z - 5 months ago

LivaNova price target raised to $67 from $58 at Barclays


LivaNova price target raised to $66 from $56 at Goldman Sachs

2026-01-09T10:56:04.000Z - 5 months ago

LivaNova price target raised to $66 from $56 at Goldman Sachs


LivaNova Transcript: Wolfe Research Healthcare Conference 2025

Nov 17, 2025, 2:40 PM EST - 7 months ago

LivaNova Transcript: Wolfe Research Healthcare Conference 2025


LivaNova Transcript: Investor Day 2025

Nov 12, 2025, 9:00 AM EST - 7 months ago

LivaNova Transcript: Investor Day 2025


LivaNova Slides: FY 2025

Nov 12, 2025, 9:00 AM EST - 7 months ago

LivaNova Slides: FY 2025


LivaNova Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:00 AM EST - 8 months ago

LivaNova Earnings Call Transcript: Q3 2025


LivaNova Quarterly report: Q3 2025

Nov 5, 2025, 8:00 AM EST - 8 months ago

LivaNova Quarterly report: Q3 2025


LivaNova Earnings release: Q3 2025

Nov 5, 2025, 8:00 AM EST - 8 months ago

LivaNova Earnings release: Q3 2025


LivaNova Slides: Q3 2025

Nov 5, 2025, 8:00 AM EST - 8 months ago

LivaNova Slides: Q3 2025


LivaNova to Announce Third-Quarter 2025 Results

Oct 8, 2025, 9:00 AM EDT - 9 months ago

LivaNova to Announce Third-Quarter 2025 Results


LivaNova Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 3:45 PM EDT - 10 months ago

LivaNova Transcript: Baird Global Healthcare Conference 2025


LivaNova Appoints Donald Zurbay as a New Director

Sep 4, 2025, 9:00 AM EDT - 10 months ago

LivaNova Appoints Donald Zurbay as a New Director


LivaNova to Host Investor Day on November 12, 2025

Aug 25, 2025, 9:00 AM EDT - 10 months ago

LivaNova to Host Investor Day on November 12, 2025


LivaNova Launches Essenz Perfusion System in China

Aug 18, 2025, 9:00 AM EDT - 10 months ago

LivaNova Launches Essenz Perfusion System in China


LivaNova Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 11 months ago

LivaNova Earnings Call Transcript: Q2 2025


LivaNova Quarterly report: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 11 months ago

LivaNova Quarterly report: Q2 2025


LivaNova Earnings release: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 11 months ago

LivaNova Earnings release: Q2 2025


LivaNova Slides: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 11 months ago

LivaNova Slides: Q2 2025


LivaNova to Announce Second-Quarter 2025 Results

Jul 9, 2025, 9:00 AM EDT - 1 year ago

LivaNova to Announce Second-Quarter 2025 Results


LivaNova Transcript: AGM 2025

Jun 11, 2025, 10:00 AM EDT - 1 year ago

LivaNova Transcript: AGM 2025


LivaNova Earnings Call Transcript: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

LivaNova Earnings Call Transcript: Q1 2025


LivaNova Quarterly report: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

LivaNova Quarterly report: Q1 2025


LivaNova Earnings release: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

LivaNova Earnings release: Q1 2025


LivaNova Slides: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

LivaNova Slides: Q1 2025


LivaNova Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

LivaNova Proxy statement: Proxy Filing


LivaNova Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

LivaNova Proxy statement: Proxy Filing


LivaNova to Announce First-Quarter 2025 Results

Mar 26, 2025, 8:00 AM EDT - 1 year ago

LivaNova to Announce First-Quarter 2025 Results


LivaNova Earnings Call Transcript: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

LivaNova Earnings Call Transcript: Q4 2024


LivaNova Annual report: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

LivaNova Annual report: Q4 2024


LivaNova Earnings release: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

LivaNova Earnings release: Q4 2024


LivaNova Slides: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

LivaNova Slides: Q4 2024


LivaNova Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 11:30 AM EST - 1 year ago

LivaNova Transcript: Stifel 2024 Healthcare Conference


LivaNova Earnings Call Transcript: Q3 2024

Oct 30, 2024, 8:00 AM EDT - 1 year ago

LivaNova Earnings Call Transcript: Q3 2024


LivaNova Quarterly report: Q3 2024

Oct 30, 2024, 8:00 AM EDT - 1 year ago

LivaNova Quarterly report: Q3 2024


LivaNova Earnings release: Q3 2024

Oct 30, 2024, 8:00 AM EDT - 1 year ago

LivaNova Earnings release: Q3 2024


LivaNova Slides: Q3 2024

Oct 30, 2024, 8:00 AM EDT - 1 year ago

LivaNova Slides: Q3 2024


LivaNova Reports Third-Quarter 2024 Results

Oct 30, 2024, 6:00 AM EDT - 1 year ago

LivaNova Reports Third-Quarter 2024 Results


LivaNova Appoints Susan Podlogar as a New Director

Oct 8, 2024, 9:00 AM EDT - 1 year ago

LivaNova Appoints Susan Podlogar as a New Director


LivaNova to Announce Third-Quarter 2024 Results

Sep 25, 2024, 9:00 AM EDT - 1 year ago

LivaNova to Announce Third-Quarter 2024 Results


LivaNova Transcript: Baird 2024 Global Healthcare Conference

Sep 10, 2024, 10:15 AM EDT - 1 year ago

LivaNova Transcript: Baird 2024 Global Healthcare Conference


LivaNova to Present at the Baird Global Healthcare Conference

Aug 19, 2024, 9:00 AM EDT - 1 year ago

LivaNova to Present at the Baird Global Healthcare Conference


LivaNova Earnings Call Transcript: Q2 2024

Jul 31, 2024, 8:00 AM EDT - 2 years ago

LivaNova Earnings Call Transcript: Q2 2024


LivaNova Quarterly report: Q2 2024

Jul 31, 2024, 8:00 AM EDT - 2 years ago

LivaNova Quarterly report: Q2 2024


LivaNova Earnings release: Q2 2024

Jul 31, 2024, 8:00 AM EDT - 2 years ago

LivaNova Earnings release: Q2 2024


LivaNova Slides: Q2 2024

Jul 31, 2024, 8:00 AM EDT - 2 years ago

LivaNova Slides: Q2 2024


LivaNova Reports Second-Quarter 2024 Results

Jul 31, 2024, 6:00 AM EDT - 2 years ago

LivaNova Reports Second-Quarter 2024 Results


LivaNova to Announce Second-Quarter 2024 Results

Jun 18, 2024, 9:00 AM EDT - 2 years ago

LivaNova to Announce Second-Quarter 2024 Results


SuperGreenToday
SuperGreenToday Jun. 3 at 4:14 AM
$LIVN Share Price: $73.35 Contract Selected: Dec 18, 2026 $70 Calls Buy Zone: $9.35 – $11.55 Target Zone: $17.22 – $21.04 Potential Upside: 74% ROI Time to Expiration: 198 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PrimeZoneNews
PrimeZoneNews May. 27 at 3:34 PM
$VVOS $LIVN As you can see under the section "Other Players": These are the only companies listed on Nasdaq. LIVN has a market cap of $4B, and VVOS has a market cap of $10M. https://www.marketsandmarkets.com/Market-Reports/united-states-sleep-apnea-devices-market-220821026.html
1 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 4:54 PM
$LIVN Current Stock Price: $70.43 Contracts to trade: $70.0 LIVN May 15 2026 Call Entry: $1.25 Exit: $1.79 ROI: 43% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SmartMoneyTradez
SmartMoneyTradez May. 7 at 7:33 PM
0 · Reply
Mogeyman
Mogeyman May. 7 at 6:30 PM
0 · Reply
The_Gambl3r
The_Gambl3r May. 7 at 3:09 AM
$LIVN $MDT $FMS $BAX $NUWE ** 👀👀
1 · Reply
Estimize
Estimize May. 6 at 10:06 PM
$LIVN reported 0.98 EPS and 263.30 revenue for Q1. http://www.estimize.com/intro/livn?chart=historical&metric_name=eps&utm_content=LIVN&utm
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 10:17 AM
$LIVN Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.41 up 106.82% YoY • Reported revenue of $362.3M up 14.34% YoY • LivaNova raised its full-year 2026 constant-currency revenue growth guidance to 7.0% to 8.0% and adjusted diluted EPS to $4.20 to $4.30, while maintaining adjusted free cash flow guidance at $160M to $180M.
0 · Reply
Estimize
Estimize May. 4 at 10:03 AM
Wall St is expecting 0.90 EPS for $LIVN Q1 [Reporting 05/06 BMO] http://www.estimize.com/intro/livn?chart=historical&metric_name=eps&utm_co
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 3 at 2:37 AM
$LIVN Current Stock Price: $70.26 Contracts to trade: $70.0 LIVN Mar 20 2026 Call Entry: $0.95 Exit: $1.53 ROI: 61% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Estimize
Estimize Feb. 25 at 11:09 PM
$LIVN reported 0.86 EPS and 360.90 revenue for Q4. http://www.estimize.com/intro/livn?chart=historical&metric_name=eps&utm_content=LIVN&utm
0 · Reply
briefingcom
briefingcom Feb. 25 at 1:12 PM
$LIVN: LivaNova beats by $0.04, beats on revs; guides FY26 EPS above consensus, revs in-line https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260225061017LIVN&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 11:13 AM
$LIVN Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.57 down -44.66% YoY • Reported revenue of $360.9M up 12.15% YoY • LivaNova PLC expects full-year 2026 revenue to grow 6.0% to 7.0% on a constant-currency basis. Adjusted diluted earnings per share is projected between $4.15 and $4.25, with adjusted free cash flow in the $160 million to $180 million range.
0 · Reply
CycleDriver
CycleDriver Feb. 18 at 3:50 PM
$LIVN LivaNova operates medical devices with exposure to cardiac and neuromodulation markets. Growth depends on procedural volumes and innovation pipeline. Margin improvement supports long-term outlook.
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 27 at 8:20 PM
$LIVN Current Stock Price: $63.92 Contracts to trade: $65 LIVN Feb 20 2026 Call Entry: $1.75 Exit: $2.25 ROI: 28% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Dec. 19 at 12:03 PM
Keybanc updates rating for LivaNova ( $LIVN ) to Overweight, target set at 81.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:05 PM
Mizuho updates rating for LivaNova ( $LIVN ) to Outperform, target set at 70 → 72.
0 · Reply